These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32259320)

  • 1. Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
    Buedts L; Smits S; Ameye G; Lehnert S; Ding J; Delforge M; Vermeesch J; Boeckx N; Tousseyn T; Michaux L; Vandenberghe P; Dewaele B
    Genes Chromosomes Cancer; 2020 Aug; 59(8):465-471. PubMed ID: 32259320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-low coverage whole genome sequencing of ccfDNA in multiple myeloma: A tool for laboratory routine?
    Rengifo LY; Smits S; Buedts L; Delforge M; Dehaspe L; Tousseyn T; Boeckx N; Lehnert S; Michaux L; Vermeesch JR; Vandenberghe P; Dewaele B
    Cancer Treat Res Commun; 2021; 28():100380. PubMed ID: 33962213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution.
    Elnenaei MO; Knopf P; Cutler SD; Sinclair K; Abou El Hassan M; Greer W; Goudie M; Wagner J; White D; Couban S; Forward N; Gaston D; Campbell CJV
    Clin Genet; 2019 Aug; 96(2):163-168. PubMed ID: 31066036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
    Höllein A; Twardziok SO; Walter W; Hutter S; Baer C; Hernandez-Sanchez JM; Meggendorfer M; Haferlach T; Kern W; Haferlach C
    Cancer Genet; 2020 Apr; 242():15-24. PubMed ID: 31980417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.
    Hayes JL; Tzika A; Thygesen H; Berri S; Wood HM; Hewitt S; Pendlebury M; Coates A; Willoughby L; Watson CM; Rabbitts P; Roberts P; Taylor GR
    Genomics; 2013 Sep; 102(3):174-81. PubMed ID: 23598253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative to array-based diagnostics: a prospectively recruited cohort, comparing arrayCGH to next-generation sequencing to evaluate foetal structural abnormalities.
    Walker L; Watson CM; Hewitt S; Crinnion LA; Bonthron DT; Cohen KE
    J Obstet Gynaecol; 2019 Apr; 39(3):328-334. PubMed ID: 30714504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
    Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
    Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate detection of copy number aberrations in FFPE samples using the mFAST-SeqS approach.
    Jary A; Kim Y; Rozemeijer K; Eijk PP; van der Zee RP; Bleeker MCG; Wilting SM; Steenbergen RDM
    Exp Mol Pathol; 2024 Jun; 137():104906. PubMed ID: 38820761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shallow whole-genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics.
    Rengifo LY; Smits S; Boeckx N; Michaux L; Vandenberghe P; Dewaele B
    Genes Chromosomes Cancer; 2023 Nov; 62(11):663-671. PubMed ID: 37293982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
    Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
    Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can genome array screening replace FISH as a front-line test in multiple myeloma?
    Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
    Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.
    Garcés JJ; Bretones G; Burgos L; Valdes-Mas R; Puig N; Cedena MT; Alignani D; Rodriguez I; Puente DÁ; Álvarez MG; Goicoechea I; Rodriguez S; Calasanz MJ; Agirre X; Flores-Montero J; Sanoja-Flores L; Rodriguez-Otero P; Rios R; Martinez-Lopez J; Millacoy P; Palomera L; Del Orbe R; Pérez-Montaña A; El Omri H; Prosper F; Mateos MV; Rosiñol L; Blade J; Lahuerta JJ; Orfao A; Lopez-Otin C; San Miguel JF; Paiva B;
    Leukemia; 2020 Nov; 34(11):3007-3018. PubMed ID: 32475991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
    Chan KC; Jiang P; Chan CW; Sun K; Wong J; Hui EP; Chan SL; Chan WC; Hui DS; Ng SS; Chan HL; Wong CS; Ma BB; Chan AT; Lai PB; Sun H; Chiu RW; Lo YM
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18761-8. PubMed ID: 24191000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
    Goldsmith SR; Fiala MA; Dukeman J; Ghobadi A; Stockerl-Goldstein K; Schroeder MA; Tomasson M; Wildes TM; Vij R
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):285-289. PubMed ID: 30792096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiconductor Sequencing Analysis of Chromosomal Copy Number Variations in Spontaneous Miscarriage.
    Wang MZ; Lin FQ; Li M; He D; Yu QH; Yang XX; Wu YS
    Med Sci Monit; 2017 Nov; 23():5550-5557. PubMed ID: 29162795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
    Smetana J; Frohlich J; Zaoralova R; Vallova V; Greslikova H; Kupska R; Nemec P; Mikulasova A; Almasi M; Pour L; Adam Z; Sandecka V; Zahradová L; Hajek R; Kuglik P
    Biomed Res Int; 2014; 2014():209670. PubMed ID: 24987674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
    Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
    Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.